Gertz BJ - Search Results

1

Porras AG, Holland SD, Gertz BJ. Porras AG, et al. Among authors: gertz bj. Clin Pharmacokinet. 1999 May;36(5):315-28. doi: 10.2165/00003088-199936050-00002. Clin Pharmacokinet. 1999. PMID: 10384857 Review.

2

Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjects.

Schwartz JI, Mukhopadhyay S, Porras AG, Viswanathan-Aiyer KJ, Adcock S, Ebel DL, Gertz BJ. Schwartz JI, et al. Among authors: gertz bj. J Clin Pharmacol. 2003 Feb;43(2):187-92. doi: 10.1177/0091270002239828. J Clin Pharmacol. 2003. PMID: 12616672 Clinical Trial.

3

Clinical pharmacology of alendronate sodium.

Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Porras AG. Gertz BJ, et al. Osteoporos Int. 1993;3 Suppl 3:S13-6. doi: 10.1007/BF01623002. Osteoporos Int. 1993. PMID: 8298197

4

Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis.

Khan SA, Kanis JA, Vasikaran S, Kline WF, Matuszewski BK, McCloskey EV, Beneton MN, Gertz BJ, Sciberras DG, Holland SD, Orgee J, Coombes GM, Rogers SR, Porras AG. Khan SA, et al. Among authors: gertz bj. J Bone Miner Res. 1997 Oct;12(10):1700-7. doi: 10.1359/jbmr.1997.12.10.1700. J Bone Miner Res. 1997. PMID: 9333131 Free article. Clinical Trial.

5

Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.

Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S. Gertz BJ, et al. Calcif Tissue Int. 1998 Aug;63(2):102-6. doi: 10.1007/s002239900497. Calcif Tissue Int. 1998. PMID: 9685512 Clinical Trial.

6

Pharmacokinetics of intravenous alendronate.

Cocquyt V, Kline WF, Gertz BJ, Van Belle SJ, Holland SD, DeSmet M, Quan H, Vyas KP, Zhang KE, De Grève J, Porras AG. Cocquyt V, et al. Among authors: gertz bj. J Clin Pharmacol. 1999 Apr;39(4):385-93. doi: 10.1177/00912709922007958. J Clin Pharmacol. 1999. PMID: 10197297 Clinical Trial.

7

Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers.

Schwartz JI, De Smet M, Larson PJ, Verbesselt R, Ebel DL, Lins R, Lens S, Porras AG, Gertz BJ. Schwartz JI, et al. Among authors: gertz bj. J Clin Pharmacol. 2001 Jan;41(1):107-12. doi: 10.1177/00912700122009755. J Clin Pharmacol. 2001. PMID: 11144988 Clinical Trial.

8

Studies of the oral bioavailability of alendronate.

Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG. Gertz BJ, et al. Clin Pharmacol Ther. 1995 Sep;58(3):288-98. doi: 10.1016/0009-9236(95)90245-7. Clin Pharmacol Ther. 1995. PMID: 7554702 Clinical Trial.

9

Effect of rofecoxib on the pharmacokinetics of chronically administered oral contraceptives in healthy female volunteers.

Schwartz JI, Wong PH, Porras AG, Ebel DL, Hunt TR, Gertz BJ. Schwartz JI, et al. Among authors: gertz bj. J Clin Pharmacol. 2002 Feb;42(2):215-21. doi: 10.1177/00912700222011139. J Clin Pharmacol. 2002. PMID: 11831545 Clinical Trial.

10

Effects of renal insufficiency and hemodialysis on the pharmacokinetics of rofecoxib.

Gottesdiener K, Agrawal N, Porras A, Wong P, Rogers JD, Gertz BJ, Redfern JS, Marbury T. Gottesdiener K, et al. Among authors: gertz bj. Am J Ther. 2003 Jul-Aug;10(4):252-8. doi: 10.1097/00045391-200307000-00004. Am J Ther. 2003. PMID: 12845388 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters